Top Officials Aim To Reshape The FDA To Prepare For 'Avalanche' Of Cancer Products



Richard Pazdur (Image via FDA) For 20 years, Richard Pazdur has run the office of the Food and Drug Administration charged with evaluating new cancer drugs, guiding the pharmaceutical industry as the business of oncology went from a relative backwater to the main event. Yesterday, as part of the $1 billion National […]



Source link
This is from today’s news)